Three-year outcomes after revascularization with everolimus- and sirolimus-eluting stents from the SORT OUT IV trial.

MLA

Jensen, Lisette Okkels, et al. “Three-Year Outcomes after Revascularization with Everolimus- and Sirolimus-Eluting Stents from the SORT OUT IV Trial.” JACC. Cardiovascular Interventions, vol. 7, no. 8, Aug. 2014, pp. 840–48. EBSCOhost, https://doi.org/10.1016/j.jcin.2014.02.014.

APA

Jensen, L. O., Thayssen, P., Maeng, M., Christiansen, E. H., Ravkilde, J., Hansen, K. N., Kaltoft, A., Tilsted, H. H., Madsen, M., & Lassen, J. F. (2014). Three-year outcomes after revascularization with everolimus- and sirolimus-eluting stents from the SORT OUT IV trial. JACC. Cardiovascular Interventions, 7(8), 840–848. https://doi.org/10.1016/j.jcin.2014.02.014

Chicago

Jensen, Lisette Okkels, Per Thayssen, Michael Maeng, Evald Høj Christiansen, Jan Ravkilde, Knud Nørregaard Hansen, Anne Kaltoft, Hans Henrik Tilsted, Morten Madsen, and Jens Flensted Lassen. 2014. “Three-Year Outcomes after Revascularization with Everolimus- and Sirolimus-Eluting Stents from the SORT OUT IV Trial.” JACC. Cardiovascular Interventions 7 (8): 840–48. doi:10.1016/j.jcin.2014.02.014.